May 27, 2022
In this episode, Drs. Matt Martinez and Sara Saberi discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and what sorts of patients are best suited for this treatment.
May 13, 2022
In this episode, Dr. Michael Shapiro and Dr. Salim Virani discuss the current treatment options for FH, including statin therapy, lifestyle modifications, and non-statin therapy.
May 9, 2022
In this episode, Dr. Michael Shapiro and Dr. Pam Taub discuss the clinical presentation, natural history, and diagnosis of familial hypercholesterolemia.